781 A randomized phase II trial of gemcitabine and either day 1 or day 8 carboplatin for advanced non-small cell lung cancer (NSCLC) von Iglesias, J., Crombie, C., Burns, W.I., Karapetis, C., Lowenthal, R.M., Kirsten, F., Davidson, J.A., Abell, F., Reece, W.H.H., DeSouza, P.

Volltext